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ABSTRACT 
The Role of Notch, Presenilin, and CBP in the Adult 
 Drosophila Central Nervous System 
 
By 
 
Randy S. Boyles 
 
Dr. Andrew Andres, Examination Committee Chair 
Associate Professor of Biological Sciences 
University of Nevada, Las Vegas 
 
Dominant mutations in Presenilin (Psn) have been correlated with the formation of 
Aß- containing plaques in patients with inherited forms of Alzheimer’s disease (AD).  
However, a clear mechanism directly linking amyloid plaques to the pathology of 
familial or sporadic forms of AD has remained elusive.  Thus, recent discoveries of 
several new substrates for Psn protease activity have sparked alternative hypotheses to 
explain the preclinical symptoms of AD.  CBP (CREB-binding protein) is a haplo-
insufficient transcriptional co-activator with histone acetyltransferase (HAT) activity that 
has been proposed to be a downstream target for Psn signaling.  Individuals with reduced 
CBP levels have cognitive deficits that have been linked to several neurological 
disorders.  However, there are contradictory reports in the vertebrate literature regarding 
the relationship between Psn activity and CBP levels.  This dissertation using Drosophila 
melanogaster, provides evidence for the first time that Psn is required for normal CBP 
levels and for maintaining global acetylations of the central nervous system of the adult 
fly.  This work also demonstrates that adult flies conditionally compromised for CBP 
display an altered geotaxis response to gravity that likely reflects a neurological defect. 
The association between Psn and CBP is most likely not direct, but through a 
signaling molecule released via Psn-mediated substrate processing.  One possible 
 iv 
candidate for this intermediate molecule is the transmembrane receptor Notch.  Notch is 
attractive because it has been shown previously to be required for long-term memory, and 
I have provided evidence here that suggests Notch is required for neurite outgrowth 
through the culturing of primary neurons of the mushroom body (a region known to be 
important for learning and memory in flies).  In addition I have located putative DNA 
binding sites for the Notch transcription factor Su(H) in the CBP enhancer, which 
suggests a regulatory role for Notch in CBP transcription.  Although this is an attractive 
model, my data do not support it.  Therefore it is likely that Notch and Psn/CBP control 
functions of the adult CNS through independent signaling molecules or pathways.  If the 
model proves correct for vertebrates, it will have a significant impact on the development 
of new therapies and pharmaceurticals agents for the treatment of Alzheimer’s disease. 
 v 
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CHAPTER 1 
INTRODUCTION 
1.1:  The Structure and Function of Presenilin. 
The Presenilin (Psn) gene encodes a nine-pass transmembrane protein that is inserted 
into the membrane as a heterodimer after being processed in the Golgi.  Functional Psn 
contains an aspartyl protease domain and is the catalytic subunit of the γ-secretase 
complex (Wolfe et al. 1999).  This complex is made up of four proteins that include:  Psn, 
nicastrin, Presenilin enhancer 2 (Pen2), and anterior pharynx-defective 1 (APH1).  It is 
suggested that the γ-secretase complex is a major contributor of regulated intramembrane 
proteolysis (RIP), which is a fairly new model that focuses on external signals coupled to 
internal ones mediated through a proteolytic event within the transmembrane (Brown et 
al. 2000). 
The participation of Psn in RIP is represented by the increasing data that implicates 
(to date) roughly 55 substrates that are processed by Psn (Beel and Sanders 2008).  The 
majority of these substrates are single pass type I transmembrane receptors (Fig. 1) 
composed of a large external domain (ECD), an intemembraneous region, and an 
intracellular domain (ICD); the most notable examples are Notch and amyloid precursor 
protein (APP) (De Strooper 1998) (Wolfe and Guenette 2007).  One known exception is 
the glutamate receptor subunit 3 (GluR3), which is a multipass glutamate receptor 
(Meyer et al. 2003).  Also, Psn associates, non-catalytically, with over 40 other proteins.  
Figure 1 (steps 7 and 8) presents two such examples using glycogen synthase kinase 3β 
(GSK3β) and N-methyl-D-aspartate receptor (NMDAR) (Parks and Curtis 2007). 
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Prior to Psn processing, the ECD undergoes “shedding” mediated by either A 
Disintegrin And Metalloproteinase (ADAM) (a metelloprotease) or β-Site of APP 
Cleaving Enzyme (BACE) (an aspartyl protease) proteolysis (Fig. 1, step 1) (Kopan and 
Ilagan 2004).  This event is prompted externally usually through ligand binding.  One 
exception to this model is APP, which apparently undergoes unregulated shedding (Ho et 
al. 2004).  This shedding of the ECD prompts the remaining portion of the receptor to be 
cleaved by Psn to free the ICD (Fig. 1, steps 2-3).  The ICD acts as a signaling molecule 
and translocates to the nucleus to affect gene transcription, usually as a coactivator (Fig. 
1, step 4).  Therefore, these gene products represent the internal consequence resulting 
from an external cue.  ADAM and BACE processing likely are the regulating step in this 
process, where Psn, depending on availability, will process these primed substrates. 
There are emerging data that suggest that Psn also has some γ-secretase-independent 
functions.  One example is the association between Psn and the Wnt-signaling component 
β-Catenin.  Psn phosphorylates β-Catenin thereby destabilizing and targeting it for 
ubiquination.  This data was acquired using a Psn mutant lacking proteolysis capabilities 
in the presence of γ-secretase inhibitors which resulted in similar β-Catenin turnover rates 
(McCarthy et al. 2005).  
Psn is conserved in Metazoans, including the Drosophila Psn which encodes a 59 kD 
protein with three known splice variants.  It is characterized best in this system for its role 
in Notch processing, because its mutant phenotype is often similar to Notch mutants, 
specifically in the development of the nervous system during bilateral cell-fate decisions 
(Artevanis-Tsakonas et al. 1999).  There are two human Presenilin genes PS1 and PS2 
that appear to be expressed in similar quantities and tissues (Sherrington et al. 1995). 
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In embryionic mice, PS double conditional knockouts (cKO), in which both PS1 and 
PS2 genes are absent, show a reduction in neural progenitor cells and the Notch target 
genes HES1 and HES5, which positively influence the cell cycle.  As adults, these mice 
have morphologically smaller brains that exhibit signs of hemorrhaging (Kim & Shen 
2008).  Furthermore, PS double cKO show signs of age-dependent neurodegeneration 
and have deficits in long-term memory (LTM), whereas STM remains intact (Saura et al. 
2004).  Also, these mice show reduced NMDAR activity, a requirement for synaptic 
plasticity, and reduced CREB-regulated gene expression, which is necessary for LTM 
maintenance (Saura et al. 2004)(Bourtchuladze et al. 1994).  
Psn was identified in 1995 (Rogaev et al. 1995) during a genetic screen involving the 
famlial form of Alzheimer’s disease (FAD).  Its implications in AD have led to a plethora 
of knowledge surrounding the importance of Psn, specifically with the multitude of 
substrates that are rapidly being discovered.  Because of this, the role of Psn as a signal 
mediator is emerging where its requirement for the proper function in both the 
developing and established nervous system suggests a necessity for neuronal survival.  
 4 
Figure 1.1:  Molecular functions of Presenilin. 
This image depicts the functions of Psn based on the most current research.  Psn is 
shown by itself in the membrane for simplicity; but it should be noted that Psn is one of 
four subunits in the γ-secretase complex. 
Step 1 shows the shedding of the external cellular domain (ECD), induced by ligand 
binding, of a generic type I transmembrane receptor mediated through either ADAM or 
BACE proteases.  Step 2 is Psn cleavage of the remaining fragment, thereby freeing the 
intracellular domain (ICD), where it translocates to the nucleus (3).  The ICD usually 
binds a transcription factor and co-activates gene expression (4). 
In step 5, the type I receptor APP is processed by a mutated form of Psn, which gives 
rise to Aβ fragments 40 and 42 amino acids in length.   These fragments, mainly Aβ-42, 
aggregate into plaques (6), which is a hallmark of AD. 
There are several proteins that associate with Psn, including Glycogen Synthase 
Kinase 3β (GSK3β), which has been shown to phosphorylate Psn (7).  Also, Psn assists 
in localizing the subunits of the N-Methyl-D-Aspartate Receptor (8).  
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1.2:  Alzheimer’s Disease – The “Amyloid” vs. “Presenilin” Hypotheses. 
 
The familial or inherited form of Alzheimer’s disease (FAD) accounts for about 5% 
of clinical cases of AD; whereas the sporadic form accounts for the rest (Hutton & Hardy 
1997).  This inherited form is thought to derive mainly from mutations in either Psn or 
APP, which is a substrate of Psn.  The mutations in Psn that give rise to AD are 
dominantly inherited and individuals with these alleles have a 100% penetrant.  Roughly 
90% of FAD cases can be attributed to mutations in Psn, and about 10% have a mutation 
in APP (Hutton & Hardy 1997).  
 The clinical signs of AD are loss of memory, progressive neurodegeneration, 
amyloid plaque formation, and neurofibrillary tangles.  Amyloid plaques, considered a 
gain of function, are considered the classical hallmark of AD and have been the focus of 
AD research for several decades.  Researchers investigating the idea that these plaques 
are the main contributor to the mechanism of AD manifestation follow what has been 
termed the “Amyloid hypothesis” (C. A. McLean et al. 2001).  This hypothesis suggests 
that mutated forms of Psn process APP in a fashion that enhances the release of a 
fragment containing 42 amino acids called Aβ42.  These apparently functionless 
fragments are not cleared and aggregate into Aβ plaques over time. This phenomenon 
also occurs with certain mutations in APP.  These plaques are often regionally associated 
with inflammation and increased presence of microglia and astrocytes, which are 
common AD-related symptoms(Griffin 2006).  Perhaps the most compelling evidence for 
this hypothesis though, is the link to Down’s syndrome.  Individuals with trisomy for 
chromosome 21 have 3 copies of APP and are usually afflicted with this disease 
(Rubinsztein et al. 1999). 
 7 
 Although there has been an exhaustive investigation into the role of Aβ42 in AD, 
there remain many unanswered questions.  The biggest problem with the Amyloid 
hypothesis is that Aβ plaques have never been correlated directly to the 
neurodegeneration associated with AD.  In fact it is not uncommon for plaques and 
neurodegeneration to occur in regionally different parts of the brain (Terry & Masliah 
1991).   Additionaly, there are several instances in which individuals show AD-associated 
dementia, but have no Aβ plaques.  Also, there are many reported cases of plaque 
formation with no signs of dementia (Snowdon 1997).   
 These accumulating gaps in Aβ research have given rise to alternative hypotheses, 
the most notable being the Presenilin hypothesis (Shen & Kelleher 2007).  This 
hypothesis suggests that the mutated forms of Psn associated with AD not only miscleave 
APP, but also many of its other substrates resulting in a loss of signal and downstream 
target gene expression.  Such signal losses have been reported with Ncadherin, Notch, 
Wnt, and reduced CRE-regulated gene expression. The idea is that any one of these, or in 
a combination, could have downstream targets that exhibit reduced expression and 
become a contributing factor to AD manifestation (Marambaud et al. 2003)(Schroeter et 
al. 2003)(Moehlmann et al. 2002)(Saura et al. 2004). 
 Furthermore, virtually all γ-secretase inhibitors, once thought of as a possible 
treatment for AD, result in reduced Psn substrate signaling and an unanticipated 
increased Aβ42 release, phenocopies with mutations in Psn.  Most, if not all, of the Psn 
substrates require modification, usually to a portion extending into the extracellular 
matrix, prior to Psn processing.  This modification occurs due to a developmental or 
external cue, such as the binding of a ligand to a receptor.  Interestingly, this is not a 
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requirement for APP, because the shedding of its extra-cellular domain is thought to be 
constitutively processed in an unregulated manner. 
The catalytic domain of Psn is thought to cleave in a rather non-specific manner.  
Based on the diversity in amino acid sequence of known cleavage sites among substrates.  
Struhl et al. (2000) suggests that the size of the extra-cellular domain of the 
transmembrane receptor determines Psn processing.  Psn passes through the membrane 
nine times, where its conformation is very important and may be controlled through 
allosteric measures, which suggests that mutations in Psn could easily alter and influence 
a fairly non-specific catalytic domain, thereby reducing Psn cleavage-induced signaling 
from its substrates.  
Saura et al. (2004) provide evidence that suggests Psn conditional knockdown mice 
have progressive age-dependent neurodegeneration, reduced synaptic plasticity, and 
hyperphosphorylated tau (concomitant with neurofibrillary tangles).  Expression of the 
human mutant form of APP gave rise to an abundance of Aβ plaques in mice and resulted 
in little to no neurodegeneration.  This further suggests that it is not a gain of function, 
but most likely a loss of function mediated through Psn that results in neurodegeneration. 
Until recently, Aβ could not be attributed to any clearly defined physiological role.  
Recent research however, reported in Soscia et al. (2010), suggests that Aβ acts as an 
antimicrobial protein (AMP), that is a component of the innate immune response.  The 
acquired immune response is excluded from the brain, and antibodies cannot pass the 
blood/brain barrier.  Interestingly, Aβ can shuttle through this barrier (Zlokovic et al. 
2000).  Soscia et al. observe that Aβ shares similar qualities of AMPs, most importantly 
its ability to aggregate into soluble oligomers.  This group conducted a screen comparing 
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Aβ oligomers to that of a very well characterized human AMP (LL-37) in their ability to 
inhibit growth of known pathogenic microbes.  Seven of twelve in the screen showed 
equal or increased antimicrobial function for Aβ.  Furthermore, temporal lobe 
homogenates from AD brains inhibited growth of Candida albicans with much more 
efficacy than non-AD brains.  This is interesting because AD brains are usually inflamed, 
which is a condition induced by the innate response. 
Based on their results, this group suggests that perhaps low levels of Aβ are released 
in the brain as a natural component of a healthy immune system.  Alternatively, 
progressively increased processing of APP over several years leads to levels that 
accumulate into plaques in AD brains.  Whether or not these plaques function as a 
neurodegenerative agent or are a uselessly accumulated AMP still remains to be 
determined.  These data do however provide an interesting insight into a putative 
physiological role for Aβ.  
There still is a large body of information that remains to be elucidated about the 
functions of these Psn-processed substrates, specifically with regards to their role in the 
nervous system and relation to each other; whether it is several independent pathways or 
one or more large networks where complex interactions can occur.  As more of their roles 
are being defined more accurate insight can be attained into the putative loss of function 
mechanism(s) that contribute to AD.  
1.3:  Notch and other Presenilin Substrates that may Influence CBP Expression. 
 CBP expression was thought to be constitutive, but recent evidence suggests that Psn 
dKO mice result in a reduction of CBP transcript and protein levels.  Intuitively, The role 
for Psn in this pathway probably exists in its substrate processing of one or more of the 
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transmembrane receptors, culminating into a transduction of an extracellular signal to an 
internal one.  The question remains, which transmembrane receptor(s) are responsible for 
taking this signal from the membrane to the nucleus to affect CBP transcription?  
The Notch receptor is an appealing candidate based on the following observations:  
Notch and CBP-reduced model systems exhibit similar phenotypes in LTM.  They also 
exhibit developmental phenotypes when they are reduced in a tissue-specific manner 
(compare wing, eye, and thorax images from both of these groups in chapter 3).   Finally, 
Suara et al. (2004) found putative DNA binding sites for Notch co-activator Su(H) in the 
mouse CBP enhancer, as did we in the Drosophila CBP enhancer, which suggests 
possible regulation by the NICD.    
Notch is a type I single-pass transmembrane receptor which is very well characterized 
in the development of the nervous system.  The gene is haploinsufficient and was named 
for its “notching” phenotype that appeared in the wings of heterozygous null Drosophila. 
During development Notch is necessary for binary cell fate decisions that result in either 
an epidermal or neuronal cell (reviewed in Artevanis-Tsakonas et al. 1999). 
The canonical Notch signaling pathway, conserved among all metazoans, starts with 
the cleavage of the extra-cellular segment of the Notch receptor induced by its 
association with a ligand, usually Delta or Serrate, presented from an adjacent cell.  The 
remaining intra-membranous and intra-cellular portion of the receptor prompt a second 
cleavage event facilitated by Psn.  This frees the Notch intra-cellular domain (NICD), 
which translocates to the nucleus to co-activate transcription (see Fig. 1)(Artavanis-
Tsakonas et al. 1999). 
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Once in the nucleus, the NICD binds and alters the transcription factor Suppressor of 
Hairless Su(H) from a repressor to an activator, which induces transcription form target 
gene expression.  In the developing nervous system Notch is responsible for activating 
the Enhancer of Split E(Sp) complex of genes, which ultimately suppress pro-neural 
genes resulting in a process called lateral inhibition (Heitzler et al. 1996).     
Although the role of Notch in development has been well described, its role in the 
post-mitotic adult system, until recently, has remained lacking and fairly unexplored.  
Notch is vital during nervous system development, any perturbation in its signaling 
results in early lethality, thereby limiting investigations into the function of Notch in the 
adult animal.  Recently, with the advent of inducible transgenes via Gal4/UAS system, we 
can now inhibit or enhance gene expression temporally (Brand & Perrimon 1993).  For 
example, where various Notch mutants may live only to a certain point in development, 
expression of an inducible Notch-RNAi transgene can remain inactive throughout 
development ensuring a complete and functioning nervous system; activation can then be 
initiated at a post-mitotic point, which will allow for the analysis of a Notch-impaired 
adult.   
Prior to the use of transgenic reagents, Notch was implicated in synaptic plasticity, 
structural plasticity, and a regulator of neurite outgrowth (Berezovska, P. McLean et al. 
1999)(Sestan et al. 1999).  Also, several cognitive diseases attribute disrupted Notch 
signaling, or at least in part, to their cause including CADASIL, Schizophrenia, and 
Alagille syndrome (Joutel et al. 1996)(Wassink et al. 2003) (L. Li et al. 1997).  
Presente et al. (2004), Costa et al. (2003), and Ge et al (2004) showed that Notch is 
required for long-term memory (LTM) in mouse and fly systems, where learning and 
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short-term memory were unaffected in the absence of Notch, likely because de novo 
protein synthesis is required for LTM. 
Although there is much interest in correlating Notch with memory at the molecular 
level, any clear insight remains ellusive.  Intuitively one would expect that Notch 
mediates gene expression through its canonical pathway via Su(H), where these gene 
products ultimately participate in the maintenance of LTM.  Also, although less widely 
known, Notch has some Su(H)-independent  activity involving the regulation of 
Armadillo/β-Catenin, which is required in Wnt signaling (Hayward et al. 2006).  Whether 
or not this regulation occurs at the DNA or protein level remains to be elucidated. 
Although it is probable that Notch influences CBP expression, which has been 
suggested in several reviews, other Psn substrates are being discovered at an increasing 
rate (Koo & Kopan 2004)(Wines-Samuelson & Shen 2005)(Parks & Curtis 2007)(Shen 
& Kelleher 2007).  The current number is 55, with an additional ~40 known proteins that 
associate with Psn.  Therefore, these interactions should be included in this investigation 
(see supplemental data). 
 Two intriguing Psn substrates that are known to associate with CBP are Ncadherin 
(Ncad) and CD44 (Marambaud et al. 2003)(Lammich et al. 2002).  Ncadherin is a type I 
receptor with its internal domain tethered to the transcription factor β-Catenin.  Upon Psn 
processing, the ICD is freed and dissociates with β-Catenin (Noll et al. 2000).  β-Catenin 
is either targeted for degradation via the Glycogen Synthase Kinase 3β (GSK3β) 
degradation complex, or it translocates to the nucleus where and binds with T-cell factor 
(TCF) and CBP to affect Wnt target gene expression.  Marambaud et al. (2003) showed, 
using mouse embryo cells, that the Ncad ICD associates with CBP in the cytoplasm and 
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targets it for degradation, therefore, in the absence of Psn, CBP protein levels actually 
increase. This is interesting because this data is in direct contrast to Saura et al. (2004) 
and the data reported in chapter 3 of this dissertation.  CD44, another Type I receptor, is a 
transcription factor for certain neural genes and has nuclear associations with CBP, 
whether this has any implications with CBP expression requires further investigation 
(Koo & Kopan 2004). 
Also, there are interesting Psn-associating proteins as well.  GSK3β, or Shaggy in 
Drosophila, as mentioned above, not only may be involved in CBP degradation, but also 
is reported to phosphorylate Psn in certain circumstances (Twomey & McCarthy 2006).  
Additionally, N-methyl-D-aspartate receptor (NMDAR) requires Psn for localizing its 
subunits prior to formation (Saura et al. 2004).  This receptor induces long-term 
potentiation (LTP), a neuronal state in LTM, and also is required for maintaining synaptic 
plasticity. 
These are just a few examples of Psn substrates or associating proteins that not only 
may influence CBP levels, but also appear to be components in overlapping pathways 
involving the nervous system.  Therefore it is possible that the regulation of CBP may 
rely on several factors drawn from a complex signaling network perhaps mediated by 
Psn.    
1.4:  The Regulation and Function of CREB-Binding Protein and Its Association 
with Neurological Disorders. 
CREB-binding protein (CBP) is a conserved gene among the more complex 
metazoans including C. elegans.  This gene encodes a multifunctional protein known 
most for its varying roles in transcriptional regulation, most notably with CREB 
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(reviewed inGoodman & Smolik 2000).  Currently CBP has been reported to associate 
with over 300 different proteins, where roughly 200 derive from genes that are 
considered essential in the mouse genome (Kasper et al. 2006)(Barrios-Rodiles et al. 
2005).        
CBP has a histone acetyltransferase (HAT) domain, which facilitates acetylation of 
N-terminal lysines on histone tails of H2B, H3 and H4.  Alternatively, CBP can perform 
factor acetylation (FAT), where acetylation occurs directly to coactivators or 
transcriptional factors (Sterner & Berger 2000)(Yang 2004).  Thus, the majority of its 
protein associations are with transcription factors, in which CBP usually acts as a 
scaffolding protein to facilitate acetylation.  This appears to be a level of transcriptional 
regulation based on the knowledge that CBP is tightly controlled at the protein level and 
is usually the limiting factor in signaling pathways.  Also, CBP regulates DNA 
replication and repair proteins like Flap endonuclease I and DNA polymerase β (Kasper 
et al. 2006). 
CBP is a large protein, over 300 kD in Drosophila, and has several domains 
including:  nuclear hormone receptor binding domain, zinc finger, kix (CREB-binding), 
bromodomain (binds lysines), HAT, and a polyglutamine stretch that aids in transcription 
(Kumar et al. 2004).  CBP appears to be expressed in all tissues and is maternally loaded. 
Two functional copies of the CBP gene are necessary because haploinsufficient null 
humans develop cognitive disorders, and Drosophila exhibit broad and severe 
developmental phenotypes (Goodman & Smolik 2000).  CBP expression was originally 
thought to be constitutive, but recently a report from Saura et al. (2004) shows that 
Presenilin conditional knockdown mice exhibit a 40% reduction in CBP expression 
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based on northern blot data, which suggests that Presenilin is somewhere upstream in 
pathway involved in the transcriptional regulation of CBP.  
CBP has been implicated in several diseases including Huntington’s disease, where 
expanded tracts of glutamines (polyQ) are translated from the mutated form of the 
Huntingtin gene.  These extra Q residues cause the protein to aggregate (Zoghbi & Orr 
2000).  These aggregations sequester CBP, most likely due to its polyQ region, and 
inhibit function (McCampbell et al. 2000).  Also, certain chromosomal translocation 
events link the histone methyltransferase-coding MLL gene or the histone 
acetyltransferase-coding gene MOZ gene to CBP, which results in a fused protein, are 
commonly seen in those afflicted with acute myeloid leukemia (AML) (Sobulo et al. 
1997)(Taki et al. 1997).  Additionally, individuals with only one functional copy of CBP 
develop a form of mental retardation, among other physical deformities, called 
Rubenstein Taybi syndrome (Rubenstein and Taybi 1963). 
 The multiple functions and associations which require CBP suggest it functions as a 
“pathway integrator” involving several signaling cascades that have broad biological 
implications.  Alterations in CBP protein levels can culminate into catastrophic results, 
especially with regards to gene transcription.  Several diseases and disorders can be 
attributed to CBP, specifically the HAT function, which is why this has become an 
increasingly successful target for therapeutic treatments.     
1.5:  The Function of Histone Acetylation and Its Role in Memory and Neurological 
Disorders. 
There are four different histone proteins; H2A, H2B, H3, and H4 that form a 
nucloesome complex.  The functional complex is an octomer assembled from two of each 
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histone type and wrapped with roughly 150 base pairs of double-stranded DNA in a tight 
configuration.  This condensed state of chromatin is concomitant with reduced levels of 
expression generically resulting from limited access to the transcriptional machinery.  
Chromatin remodeling is usually necessary for transcription and the four most common 
methods are: acetylation, phosphorylation, methylation, and ubiquination (reviewed in 
Berger 2007), where acetylation is probably the best understood.   
Acetylation occurs through the enzymatic transfer of acetyl groups to Lysine residues 
located on histone tails.  This is accomplished by proteins that contain histone 
acetyltransferase (HAT) domains, and their removal occurs via histone deacetylase 
proteins (HDACs).  Acetylation reduces the electronegative charge of the Lysine, thereby 
making the DNA less attractive to the histone resulting in a more relaxed state, which 
ultimately allows for increased transcription. 
The state of chromatin is highly dynamic and complex.  The expressive state relies on 
several things including type, number, and arrangement of these combinatorial 
modifications.  These modifications impart a very influential level of transcriptional 
regulation that can occur epigenetically or through an external signal.  With regards to 
acetylation, the ratio between HATs and HDACs directly correlates to the modified state 
of the chromatin. For example, the addition of HDAC inhibitors to a system results in 
increased acetylation, whereas reduced levels of specific HAT proteins result in 
decreased acetylation levels.   
HAT acetylation can occur globally, encompassing large distances of chromatin, or 
locally, at specific promoter sites (Cheng et al. 2008).  HATs are evolutionarily 
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conserved from Yeast to humans and fall into three groups based on their acetylating 
domain, and they are:  CBP/p300, GNAT, and MYST (Lee and Workman 2007).    
CBP is perhaps the best characterized HAT based on its role in CREB coactivation at 
CRE-containing gene regulatory regions.  Phosphorylated CREB recruits CBP to these 
enhancers where histone acetylation occurs locally prior to transcription.  The importance 
of CREB regulation is seen through its emerging cognitive role, specifically with regards 
to long-term memory (LTM) (reviewed in Yin and Tully 1996).  Also, CBP recently has 
been implicated in memory.  Alarcon et al. (2004) and Korzus et al. (2004) show that 
CBP mutant mice have LTM deficits that can be ameliorated through the use of HDAC 
inhibitors, which suggests that the LTM phenotype derives from reduced levels of histone 
acetylation. 
The use of HDACs to modulate memory is a common practice, but Stefanko et al. 
(2009) show that HDAC inhibitors can actually increase wildtype memory in mice.  LTM 
retention remained far longer in HDAC-inhibited mice compared to mice with normal 
memory.  Also, they show that a training regimen designed for retention to last only in 
the short-term (STM), persists into LTM in HDAC-inhibited mice. 
Acetylated states are clearly a regulatory mechanism governing transcription; 
therefore, any disruption in this process can contribute to diseases ranging from mental 
retardation, schizophrenia, Huntington’s and Alzheimer’s disease, Fragile X, and certain 
types of cancers.  These are compelling reasons to shift research focus to histone 
acetylation as a therapeutic target in an attempt to arrest or ameliorate the affects of these 
diseases.  
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Drosophila Stocks and Culture. 
All flies were raised on standard cornmeal-molasses medium supplemented with live 
baker's yeast using the recipe recommended by the Bloomington Stock Center 
(Bloomington, Indiana, United States) (http://flystocks.bio.indiana.edu/Fly_Work/media-
recipes/bloomfood.htm).   
The stocks listed below were obtained from Bloomington:  w1118 (FBst0307124), hs-
CBP+ (FBst0003730), UAS-Psn+ (FBst0008309), UAS-Psni [selected as described 
below (FBst0008317)], GMR-Gal4 (FBst0001104), pnr-Gal4 (FBst0003039), and UAS-
Ni (FBst0007078). 
The following stocks were obtained as gifts:  hs-N+ and c96-Gal4 (Rebay et al. 1993) 
from S. Artevanis-Tsakonas;  UAS-CBP+ and UAS-CBPi (Kumar et al. 2004) from J. 
Kumar; UAS-CBP-FLAD (Ludlam et al. 2002) from S. Smolik; and hsGal4 (Brand & 
Perrimon 1993) from R. Holmgren; 247-Gal4  (Zars et al 2000) from J. Steven deBelle. 
The following lines were used in RNAi screen, but were not used further in this 
report:  UAS-Psni-43082 ,Vienna Drosophila RNAi Center (Dietzl et al. 2007), UAS-Psni 
(FBst0008318 and FB0008316).    
2.2:  Generation of Transgenic UAS-Psni Fly Lines. 
Two separate DNA fragments of 262 base pairs were amplified from the ninth exon 
of the Drosophila Psn gene using two separate primer sets (Integrated DNA 
Technologies Coralville, Iowa, United States).  The first primer set 
(GGGAATTCGGCATAAAGCTTGGCCTC and 
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GGCTCGAGTATAAACACCTGCTTGGC) produced a fragment that was digested with 
EcoRI and XhoI and directionally cloned into the corresponding sites of the pWIZ vector 
downstream of UAS sequences (Takemaru et al. 2003).  The second primer set 
(GGGCTAGCTATAAACACCTGCTTGGC and 
GGTCTAGAGGCATAAAGCTTGGCCTC) amplified the same piece of DNA.  
However, it was digested with NheI and XbaI and directionally cloned into pWIZ to 
produce an inverted repeat of the first fragment.  The completed pWIZ-Psni construct was 
send to the Holmgren Lab (Northwestern University, Evanston, Illinois, United States) 
for the production of transgenic flies using standard techniques.  Eight transgenic lines 
were produced:  UAS-Psni-J1, UAS-Psni-J2, UAS-Psni-J3, UAS-Psni-J5, UAS-Psni-J7, 
UAS-Psni-2a, UAS-Psni-2b, and UAS-Psni-15. 
2.3:  Selecting an effective UAS-Psni Line. 
While we were generating the eight UAS-Psni transgenic flies described above, four 
independently produced lines became available from the Drosophila community.  All of 
these contained inverted repeats of Psn sequences under UAS control.  Three lines came 
from Bloomington: FBti0040721, FBti0040747, FBti0040722; and one line from the 
Vienna Drosophila RNAi Center (UAS-Psni-43082) (Dietzl et al. 2007). 
We tested all 12 lines by expressing them in the developing wing, thorax, and eye 
(Fig. 2C,G,K) and selected the one line that produced the most severe phenotypes. 
2.4:  Western Blotting. 
Protein extracts using Drosophila were prepared as described in (Vecsey et al. 2007).  
They were removed from anesthetized flies of the appropriate genotype with a razor 
blade and homogenized in a lysis buffer (1% NP-40, 0.5% deoxycholic acid, 0.1% 
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Triton-X-100, 100 mM NaCl, 0.1 mM CaCl2, 2 mM MgCl2) supplemented with freshly 
prepared protease inhibitor cocktail (Sigma-Aldrich Inc. St. Louis, Missouri, United 
States) to a final concentration of 1%.  Cell debris was pelleted in a microfuge (1000 g 
for 1 minute) and the supernatant was transferred to an equal volume of 2x Laemmli 
buffer (2x=4% SDS, 20% glycerol, 120 mM Tris pH 6.8, 10% β-mercaptoethanol, 
0.002% bromophenol blue).   The equivalent of 7.5 heads for Notch detection and 2.5 
heads for CBP detection was boiled for 5 minutes and loaded on a 7.5% polyacrylamide 
gel.   
Gels were blotted and treated with antibodies using a modified protocol of (Vaskova 
et al. 2000).  After electrophoresis, the gel was electroblotted onto an Immobilon-P 
membrane (Millipore, Bedford, Massachusetts, United States) for 2.5 hours and blocked 
overnight in PBST (1.4M NaCl, 26.8mM KCl, 101.4 mM Na2PO4, 17.6mM KH2PO4, and 
1% Tween 2) plus 5% dry milk (Nestle USA, Inc., Solon, Ohio, United States) at 4°C.  
The following primary antibodies were used:  rabbit polyclonal anti-dCBP (a gift from 
Alexander Mazo) diluted 1:1000, mouse monoclonal anti-Notch C17.9c6 (Developmental 
Studies Hybridoma Bank, University of Iowa, Iowa City, Iowa, United States) diluted 
1:2000, and mouse monoclonal anti-α-tubulin (Sigma-Aldrich) diluted 1:15000.  Primary 
antibody incubation was done in PBST and 5% milk overnight at 4°C.  Goat-anti-mouse-
HRP diluted 1:25,000 and Goat-anti-rabbit-HRP diluted at 1:40000 (Jackson Immuno 
Research, West Grove, Pennsylvania, United States) were used as secondary antibodies.  
An ECL Plus Detection System (GE Healthcare, Piscataway, New Jersey, United States) 
was used for protein detection and visualized on a Typhoon 8600 Variable Mode 
Phosphorimager (GE Healthcare). 
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2.5:  Immunohistochemistry. 
Flies of the appropriate genotype were selected from progeny that were raised at 18°C 
and collected 3-5 days post eclosion.  They were subjected to a heat shock regimen to 
induce the proper transgene by either being moved to 29°C for the duration of the 
experiment or by being immersed in their culture tubes in a 37°C water bath as described 
below.  Brains dissected in PBS (1.9 mM NaH2PO4, 8.4 mM Na2HPO4, 175 mM NaCl), 
were fixed in 4% paraformaldehyde (in PBS), and treated with primary and secondary 
antibody (Wulbeck & Helfrich-Forster 2007).  The following primary antibodies were 
used:  rabbit polyclonal anti-CBP (Alexander Mazo) diluted 1:350 in PBSBT (PBS, 0.2% 
Triton-X100, 0.25% BSA) and rabbit polyclonal anti-Ac-H4-K8 (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA United States) diluted 1:350 in PBSBT.  Incubation 
in primary antibody occurred overnight with gentle rocking at 4°C.  After washing 3-5 
times in PBT (PBS, 0.2% Triton-X100) the brains were incubated with Rhodamine-
conjugated goat-anti-rabbit secondary antibody (Jackson Immuno Research), diluted 
1:1000 in PBSBT for 4 hours at room temperature.  The final washes (3 x 5 minutes 
followed by 3 x 20 minutes) were done in PBT.  The tissues were mounted in Fluoro-Gel 
(Electron Microscopy Sciences, Hattfield, Pennsylvania, United States) and imaged on a 
LSM 510 Axioplan confocal microscope (Carl Zeiss SMT, Peabody, Massachusetts, 
United States) equipped with LSM 510 image-analysis software (Carl Zeiss). 
2.6:  Quantative Real-Time (qRT) PCR. 
RNA was extracted from 100 adult Drosophila heads using the RNeasy Mini Kit 
(Qiagen Valencia, California, United States) and treated with Turbo DNA-free (Ambion 
Austin, Texas, United States) using their respective protocols.  cDNAs were synthesized 
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using SuperScript First-Strand (Invitrogen, Carlsbad, California, United States) according 
to manufacturer’s instructions.  GAGCAGGCGGTAATCTTCAG and 
TTGCTGGGGAAGAACTATGG primers (Integrated DNA Technologies) and PerfeCTa 
SYBR Green SuperMix (Quant Biosciences, Gaithersburg, Maryland, United States) 
were used to amplify and detect CBP sequences during the reactions.  Each reaction was 
performed in triplicate on a Bio-Rad iCycleriQ Real Time PCRSys system (Bio-Rad 
Laboratories, Hercules, CA United States), and experimental Ct values were normalized 
to Beta-Actin using TCTACGAGGGTTATGCCCTT and 
GCACAGVTTCTCCTTGATGT primers.  The data were subjected to ΔΔct statistical 
analysis.  
2.7:  Primary Neuron Culture. 
Brains dissected from wandering third instar were used for primary neuron cultures, 
where transgenic expression was confined to the mushroom body via the 247-gal4 diver.  
These neurons were identified with green fluorescent protein (GFP) using the following 
groups:  UAS-Ni;UAS-GFP/247-gal4 (experimental) and UAS-GFP/247-gal4 (control).  
The larvae were initially sterilized in 95% ethanol for 1 minute, washed 3 times in water, 
and transferred to a well containing Schneider’s Insect Media (Invitrogen, Carlsbad, CA) 
with 10% fetal bovine serum (Hyclone, Logan, UT), and 50 µg/ml of insulin (Sigma, St. 
Louis, MO).  Brains were incubated at room temperature for 1 hour in a dissociation 
media containing 1X Liberase (Roche) and Rinaldini’s saline (137mM NaCl, 2.68 mM 
KCl, 0.36 mM NaH2PO4 , 11.9 mM NaHCO3, and 5.55 mM glucose).  For a complete 
dissociation, the brains were pipetted through a P-200 tip for 40 repetitions for two 
rounds in 200µl of media.  The final volume was adjusted to 500µl, where 100µl aliquots 
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were distributed among 5 culture dishes featuring a small circular well containing 
167µg/ml of Concanavilin A (Sigma) and 1.67µg/ml laminin (BD Biosciences, Bedford, 
MA).  The cells were given two hours to attach to this surface before flooding the dish to 
a final volume of 1ml.  The dishes were sealed with two strips of parafilm and incubated 
at 25°C for 3 days for neurite growth prior to analysis. 
The cultured primary neurons were analyzed on a free access semi-automated 
computer program called Neuronmetrics (http://www.ibridgenetwork.org/arizona/UA07-
56-Neuronmetrics).  The neurites were evaluated for the following characteristics: total 
neurite length, branchiness, number of primary neurites, and territory occupied by 
neuron.  These measurements were statistically analyzed by a Mann-Whitney rank sum 
test using GraphPad Prism software.   
2.8:  Heat Shock Treatments. 
For experiments that involved the conditional induction of transgenes, flies were 
raised at 18°C until 3-5 days post-eclosion.  They were then either moved to 29°C (for 
experiments using UAS-CBP-FLAD) or subjected to heat shocks in a 37°C waterbath (for 
experiments involving UAS-Ni, UAS-Psni, UAS-CBPi, UAS-N+, UAS-Psn+, UAS-
CBP+).  Prior to administering the heat shocks, flies were transferred to 9.5x2.5 cm 
polypropylene vials containing 8 ml of cornmeal-molasses medium covered with a thin 
layer of rayon to protect them from dehydration and getting stuck in the food.  Buzz 
plugs (Genesee Scientific, San Diego, California, United States) were used to create a 
chamber that was submerged in the water bath.  Conditions for multiple heat shocks were 
determined empirically for each genotype to maximize target-gene silencing (determined 
by Western blot) without causing lethality.   
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The following heat shock regimens were used:  7 one-hour treatments (~12-14 hours 
apart) for CBPi (hsGal4; UAS-CBPi) and controls; 9 one-hour treatments (~12-14 hours 
apart) for Ni (hsGal4; UAS-Ni), Psni (hsGal4; UAS-Psni), and their control groups; 7 
one-hour treatments (~12-14 hours apart) for Psn+ (hsGal4; UAS-Psn+) and controls; 
and 2 one-hour treatments (~12-14 hours apart) for N+ (hsN+), CBP+ (hsCBP+ and 
hsGal4; UAS-CBP+), and controls.   
Flies recovered between heat shocks at 25°C and were given a one-hour rest period at 
25°C after the last treatment before their brains were dissected. 
2.9:  Geotaxis Response Assay. 
 All geotaxis experiments were performed in a countercurrent apparatus as described 
in Benzer (1967).  The apparatus consists of 6 sets of polypropylene tubes (9 x 1.5 cm) 
horizontally opposed.  The opposing tubes are held in a plexiglass frame that allows the 
tubes to move in unison relative to each other.  The experiments were conducted without 
light in an environmentally controlled chamber at 25°C with 65% relative humidity, and 
all fly lines were outcrossed for 7 generations to reduce the occurrence of modifiers.  
Roughly 25 flies of mixed sex were used per round.  Flies are given a score based on 
how far they advanced by the conclusion of the round.  The percentage of the cohort in 
tube 6 was multiplied by 1, those in tube 5 by 0.8, those in tube 4 by 0.6, those in tube 3 
by 0.4, those in tube 2 by 0.2 and those in tube 1 by 0.  These scores were totaled for each 
round and the mean and standard error were calculated based on a total of twelve 
different rounds.  All groups were compared for significance using a one-way ANOVA 
using GraphPad Prism software (La Jolla, CA United States). 
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2.10:  Accession Numbers. 
The FlyBase (http://flybase.bio.indiana.edu/search/) identification numbers are used 
in this work to describe genes, gene products, vectors, and Drosophila stocks. 
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CHAPTER 3 
PRESENILIN CONTROLS CBP FUNCTION IN DROSOPHILA	  
The following chapter was the submitted to journal PLoS One for publication with the 
following author list:  Randy S. Boyles, Katheryn M. Lantz, Steven Poertner, and 
Stephanie J. Georges, and Andrew J. Andres. 
My contribution to this work is as follows:  Designed every experiment, performed all of 
the molecular biological experiments, performed or directed all of the cell biological 
experiments.  I also performed all qRT-PCR experiments and bioinformatic analyses.  
My undergraduate assistants participated in immunohistochemistry assays involving 
acetylation levels, and also geotactic experiments, and transgenetic outcrossing.  All of 
the fly lines were either collected or made by me except hs-N, hs-gal4, and UAS-Ni.      
3.1:  Introduction. 
In humans, functional Psn, the catalytic subunit of the γ-secretase complex, is a nine-
pass transmembrane protein that contains an aspartyl protease domain.  Psn is best 
characterized for its role in early onset familial forms of Alzheimer’s disease (FAD).  
Patients with FAD often have single gain-of-function mutations in Psn that are thought to 
process amyloid precursor protein (APP) in a manner that releases amyloid (Aβ) 
fragments into the extracellular matrix.  These fragments, usually 40 and 42 amino acids 
in length, aggregate into the amyloid plaques that are often considered a hallmark of 
Alzheimer’s Disease (AD) (Tanzi & Bertram 2005). 
Psn is known to cleave 55 substrates (Beel & Sanders 2008), the majority of which 
are single-pass Type-I Transmembrane Receptors that include Notch and APP (Parks & 
Curtis 2007).  Prior to Psn processing, ligand binding usually activates a metalloprotease 
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that processes the extracellular domian (ECD) of the receptor.  The truncated receptor 
then becomes a substrate for Psn, which processes it further to release the intracellular 
domain (ICD) from the membrane.  The ICD normally translocates to the nucleus to co-
activate gene transcription.  Thus, this regulated intramembrane proteolysis (RIP) activity 
of Psn (Hass et al. 2009) couples external signals to changes in the transcription pattern 
of target genes.   
Although extensive investigations have attempted to demonstrate the causative action 
of amyloid plaques in the manifestation of Alzheimer’s disease (AD), no clear 
mechanism has been demonstrated for how these plaques cause the overall neurological 
disease (reviewed in Shen & Kelleher 2007), (Wines-Samuelson & Shen 2005), and 
(Hass et al. 2009)).  Thus, elucidating the signaling pathways controlled by Psn remains 
an important area of basic research that could impact future treatments of AD. 
 One interesting candidate gene that may be regulated through Psn processing 
encodes CBP [Cyclic-AMP-Response Element-Binding (CREB)-Binding Protein].  CBP 
is promiscuous and known to interact with over 300 different substrates, 200 of which are 
categorized as essential in the mouse genome (Kasper et al. 2006), (Barrios-Rodiles et al. 
2005).  It is a multi-functional protein that can co-activate transcription factors, bridge 
enhancer-binding complexes, and acetylate histones (reviewed in (Goodman & Smolik 
2000)).   Thus, it is often the limiting factor or signal integrator in many important 
pathways that control nervous system activities.  Null mutations in CBP are homozygous 
lethal, but hypomorphs and haploinsufficiencies have been linked to human cognitive 
disorders including Huntington’s disease and Rubenstein Taybi disease, a developmental 
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defect characterized by reduced mental functions (McCampbell et al. 2000), (Rubinstein 
and Taybi 1963). 
The association between Psn and CBP is unlikely to be direct, but mediated through 
one or more of the several Psn-processed substrates.  Previously we have shown a 
requirement for Notch in the Long-Term-Memory (LTM) of flies (Presente et al. 2004), 
and we are testing a molecular model whereby Notch signaling acts as an intermediate 
between Psn and CBP.  In this report we examine the conflicting relationship between 
Psn, Notch, and CBP using the conditional genetic reagents of the Drosophila model 
system (Saura et al. 2004), (Marambaud et al. 2003).  Because CBP is needed for many 
higher order cognitive functions in flies and vertebrates, we are confident that important 
aspects of the signaling mechanism will be conserved between the two systems.  
However, although our data suggest that Psn is necessary for CBP expression and global 
chromatin acetylation in the adult fly brain, these activities are not dependent on a simple 
mechanism whereby Psn processes Notch into a transcriptional co-activator that regulates 
CBP expression. 
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3.2:  Results. 
3.2.a:  Phenotypic-Based Analysis of Transgenic RNAi Lines. 
Psn is emerging as an important signal integrator in which external cues are 
transmitted internally through signaling cascades that affect many cellular processes 
including changes in gene expression.  Because Psn contains an aspartyl protease domain, 
its primary role in this process is thought to occur through proteolytic processing of Type 
I Transmembrane Receptors. Furthermore, the link between mutation in Psn and 
inherited forms of AD has placed a premium on trying to understand the intricate 
signaling network mediated by this complex.  The powerful genetic tools unique to 
Drosophila are particularly valuable in trying to understand this signaling mechanism 
because the Gal4/UAS binary expression system (Brand & Perrimon 1993) can be used to 
over-express and/or silence virtually any gene in the organism in a temporally and 
spatially specific manner. 
We began this analysis by first trying to understand what happens to flies when 
protein levels of Psn, Notch, and CBP are reduced in the adult nervous system.   Our 
approach was to use an inducible-RNAi strategy that allows these genes to be fully 
functional during embryonic and larval development, but to silence them in selected adult 
tissues.   
We have previously described the generation and characterization of several 
transgenic lines of flies that placed an inverted repeat of Notch sequence under control of 
GAL4 transcription factor binding sites (UAS elements).  We produced 24 lines and we 
showed that all could selectively silence the Notch gene to some degree.  However, we 
demonstrated that one line, UAS-Ni-14E (hereafter referred to as UAS-Ni) effectively 
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reduced the accumulation of Notch protein (as judged by Western analysis) and 
eliminated Notch signaling when expressed in target tissues (Presente et al. 2002).  For 
example, Notch signaling has been shown by mutant analysis to be required for the 
proper specification of the wing margin (De Celis et al. 1996).  Thus, when UAS-Ni is 
expressed in that tissue using the c96-Gal4 driver, the wing margin is dramatically 
scalloped and almost devoid of trichomes (Fig. 3.2B).  Notch is also required for proper 
patterning of macrochete and microchete sensory bristles on the thorax (Heitzler & 
Simpson 1993), and when UAS-Ni is expressed in that tissue using a pnr-Gal4 driver, a 
disruption of bristle pattern and balding is apparent (Fig 3.2F).  Finally, it has been 
demonstrated that Notch is needed for R8 photoreceptor specification in the developing 
eye disc (Baker & Yu 1998), and when it is silenced in developing eye disc with the 
GMR-Gal4 driver, the eye appears disorganized and roughened (Fig. 3.2J). 
Because Psn is known to process Notch into a signaling molecule, we used the same 
logic to judge the effectiveness of twelve UAS-Psni lines generated in our lab or collected 
from the Drosophila community (Fig. 3.1).  The most efficacious line produced wrinkles 
and notches in the wing blade (Fig. 3.2C), bristle fusion and elimination on the thorax 
(Fig. 3.2G), and roughening of the eye (Fig. 3.2K).  
Finally, because we expected Psn, Notch, and CBP to be involved in a related 
molecular pathway (see below), we examined the phenotypes produced when CBP was 
silenced with RNAi.  We obtained a UAS-CBPi line that was shown to be an effective 
reagent for silencing the endogenous CBP gene (Kumar et al. 2004).  Interestingly, when 
we expressed the UAS-CBPi construct in the same three tissues using the same three 
drivers, we observed similar phenotypes to those seen when Notch and Psn were 
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silenced:  wrinkles and notches in the wing blade (Fig. 3.2D), machrochete fusion (Fig. 
3.2H, arrows and insert), and a roughened appearance of the eye Fig. 3.2L).   
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Figure 3.1:  Design of UAS-Psni. 
A 262-base sequence was amplified by polymerase chain reaction (PCR) from the 
ninth exon of Psn from genomic DNA.  Two primer sets were used for a sense and 
antisense PCR product with the appropriate restriction enzyme sequences added.  Both 
the sense and antisense products were directionally cloned into a pWIZ vector at the 
multiple cloning site (MCS).  The finished vector was injected into fly embryos to be 
taken up into their own genomic DNA.   
There are upstream activating sequences (UAS) located upstream of the MCS which 
allow for conditional expression in the presence of Gal4 protein.  Upon expression the 
Psni transcript, which contains complimentary sequences, will flip back on itself and a 
double-stranded RNA fragment will result.  This will prompt the RNA-interference 
cascade, which will ultimately limit the number of endogenous RNA transcripts for 
translation and subsequently reduce protein levels.     
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Figure 3.2: Developmental phenotypes of flies compromised for Notch, Psn or 
CBP using transgenic RNAi. 
(A) represents a wildtype wing and (B-D) are examples of the UAS-RNAi lines 
crossed to c96-Gal4.  Silencing either gene with this driver results in irregular or missing 
wing margins and wrinkling and notching of the wing blade.  (E) is a wildtype thorax and 
(F-H) are representative samples of the UAS-RNAi lines crossed to pnr-Gal4.  Silencing 
the genes with this driver leads in improper sensory organ development that gives rise to 
balding and/or supernumerary machrochete on the thorax and notum.  (I) is a wildtype 
eye and (J-L) represent UAS-RNAi lines crossed to GMR-Gal4, which causes blistered 
and fused ommatidia, and with the Psn knockdowns in particular (J), sporadic elongated 
sensory hairs. 
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3.2.b:  Presenilin Regulates CBP in a Notch-Independent Manner. 
We and others have demonstrated that Notch is needed for long-term memory (LTM) 
in flies and mice (Presente et al. 2004), (Ge et al. 2004), and (Costa et al. 2003).  Others 
have also shown that the CREB transcription factor is important in the same process in 
the same organisms (Bourtchuladze et al. 1994), (Mantamadiotis et al. 2002), and that a 
key co-activator of CREB-mediated transcription is CBP.  CBP is also required for LTM 
(Lonze & Ginty 2002), and has been hypothesized to be a target gene for Notch signaling 
(Saura et al. 2004).  Thus, we began testing a model in which the Psn-dependent release 
of the Notch ICD transcriptionally controls the expression level of CBP in the adult 
nervous system of flies. 
To test this hypothesis, we first examined the genomic DNA surrounding the CBP 
transcription unit and its flanking regions for Su(H)/CBF1/RBP-Jκ (a transcription factor 
co-activated by Notch) binding sites.  We identified four sites that matched the reported 
consensus sequences (Nellesen et al. 1999).  These occurred upstream and downstream  
(within the first intron) relative to the start of transcription (Fig. 3.3), and the presence of 
these elements strengthened the model that CBP is transcriptionally regulated by the 
Notch ICD. 
To test this possibility further, we analyzed CBP protein levels in adult flies in which 
Notch had been silenced with RNAi.  The Western analysis in Fig. 3.4 shows that when 
Notch is compromised (hsGal4; UAS-Ni, + heat shocks), CBP protein levels are similar 
to those detected in the controls [(no Gal4; UAS-Ni; + heat shocks) and (hsGal4; UAS-Ni; 
no heat shocks)].  Similar levels of CBP protein were also observed when control and Ni 
adult brains were compared using immunohistochemistry (Fig. 3.5).  We further analyzed 
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the effects of Notch on CBP expression using qRT-PCR to measure CBP RNA levels 
from animals in which we either silenced Notch (with UAS-Ni) or overexpressed it (with 
hsN+) (see supplemental data).  The results indicated that there was not a significant 
difference in CBP transcripts when these samples were compared to normalized wildtype 
levels. 
Taken together, these results suggest that the impaired LTM phenotype associated 
with Notch loss-of-function in the adult central nervous system cannot be easily 
explained by an appreciable effect on the expression of the CBP gene. 
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Figure 3.3:  Putative Su(H) DNA binding sites in the CBP enhancer. 
The CBP locus, including 2.5kb upstream of the transcription start site, reveals three 
occurrences of the putative Su(H) binding sites RTGRGAR and YGTGRGAA and one in 
the first intron.  From the start of transcription, the upstream site locations are -388, -
2064, and -2112, whereas the downstream site is at +353. 
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Figure 3.3 
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Figure 3.4:  Notch is not required for CBP expression. 
 This image represents a Western analysis of Notch and CBP protein levels under 
conditions in which Notch is silenced with RNAi by applying multiple heat shocks (see 
materials and methods).  Two blots were made from each protein sample.  One blot was 
incubated with Notch antibody (top row) and the other was incubated with CBP antibody 
(3rd row).  Both blots were cut and incubated separately with tubulin antibody to serve as 
a control for protein loading and transfer (2nd and 4th rows).  
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Figure 3.5:  Notch dysfunction brains. 
 
Both (A and B) are confocal images of dissected brains from control (no Gal4, UAS-
Ni) and Notch-silenced experimental animals (hsGal4; UAS-Ni).   Both groups were heat-
shocked using the same regimen as B, and both were stained with CBP antibody and 
imaged using the same conditions and microscope settings. 
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Figure 3.5 
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3.2.c:  Presenilin is Necessary for CBP Expression. 
Although we failed to establish a link between Notch and the expression of CBP, 
there are reports in the literature describing a connection between Psn and CBP (Saura et 
al. 2004), (Marambaud et al. 2003).  Thus, we used this transgenic RNAi strategy to 
ascertain whether CBP would be affected when Psn was silenced in adult flies. 
As shown in the Western-blot analysis of Fig. 3.6, there is a ~90% reduction in CBP 
protein in the Psn-reduced lane (hsGal4; UAS-Psni; + heat shocks) compared to the 
control (no Gal4; UAS-Psni; + heat shocks).   In addition, a 20-fold increase in CBP 
transcript was observed by qRT-PCR when a wildtype construct of Psn was overexpresed 
with a heat shock driver (see supplemental data).  Finally, in order to investigate whether 
Psn affects CBP accumulation in specific regions of the adult central nervous system, we 
performed antibody staining on dissected brains.  Shown are representative examples of 
confocal Z-stack images of whole mounts from control [no Gal4; UAS-Psni; + heat 
shocks (Fig. 3.7B] and experimental [hsGal4; UAS-Psni; + heat shocks (Fig. 3.7A)] 
groups.  Clearly, there is a dramatic reduction in the amount of CBP protein detected 
when Psn is silenced.  These data suggest that CBP is regulated by Psn in Drosophila, 
and given that Psn functions as membrane-bound catalytic subunit of the g-secretase, the 
mechanism probably requires intermediate signaling molecules.  
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Figure 3.6:  Psn is necessary for maintaining proper CBP protein levels in the adult 
Drosophila CNS. 
(A) shows a Western analysis from fly heads in which CBP protein levels are reduced 
>90% (hsGal4; UAS-Psni; + heat shocks) compared to the controls (heat shocked 
animals without a driver or an RNAi responder) using Tubulin as an internal standard for 
protein loading and transfer. 
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Figure 3.6 
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Figure 3.7:  Dissected adult brains stained for CBP in a Psn-reduced background. 
The following images are dissected brains stained with anti-CBP: Figure (A) hsGal4; 
UAS-Psn, and (B) no Gal4; UAS-Psni brain.  Both groups were given the heat shock 
treatment.   
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Figure 3.7 
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3.2.d:  Global Acetylation Levels of H4 are Reduced in the Brain when the HAT Domain 
of CBP is Disrupted. 
Because the previous data suggest that Psn is required for CBP expression, we expect 
that phenotypes associated with mutations in Psn should overlap with mutations in CBP.  
Thus, one function of CBP that is critical to an active cell is the histone acetyl-transferase 
(HAT) function that modifies nucleosomes, presumably so that they can be more easily 
displaced by the transcription machinery.   Therefore the HAT activity of CBP could 
influence the acetylation of a few nucleosomes at key gene targets such as those that 
contain CRE elements for CREB-regulated transcription (Vecsey et al. 2007), or it might 
have global effects on chromatin structure throughout the genome (Cheng et al. 2008).   
To distinguish between these two possibilities, we used a dominant-negative variant 
of CBP in which the HAT domain is disrupted (UAS-CBP-FLAD) (see (Ludlam et al. 
2002) for a complete description).  When expressed in developing tissues, UAS-CBP-
FLAD produces a roughened eye (Fig. 3.8A) and a notched wing (Fig. 3.8B, arrowhead), 
similar to the phenotypes observed when UAS-CBPi is expressed in the same tissues (Fig. 
3.2D,L).  We next compared whole-mount brains of control and UAS-CBP-FLAD adults 
for global acetylation levels by staining them with a well-characterized antibody that 
specifically recognizes acetylated Lysines (at position 8) of Histone 4 (AC-H4-K8).  As 
shown in Figure 3.9, a dramatic reduction in AC-H4-K8 staining was observed when 
control brains (Fig. 3.9A) were compared to those expressing the UAS-CBP-FLAD 
construct (Fig. 3.9B). 
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Figure 3.8:  Expression of UAS-CBP-FLAD in developing tissues results in a 
consistent phenotype.	  
(B) depicts a typical roughened eye phenotype produced with UAS-CBP-FLAD is 
expressed with the GMR-Gal4 driver during development.  (D) displays a wing 
phenotype with a prominent notch (arrowhead) that is typically observed with UAS-CBP-
FLAD is expressed with the c96-Gal4 driver (A and C are WT).  Both phenotypes are 
similar to those detected with UAS-CBPi is expressed with the same drivers (Fig. 3.2).  
	  
 51 
Figure 3.8 
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Figure 3.9: The HAT domain of CBP is required for acetylation of histone 4 at 
Lysine 8 in the adult Drosophila CNS. 
 (A) is a control brain (no Gal4; UAS-CBP-FLAD; + heat shocks) stained for 
acetylated Histone 4, and (B) is an experimental brain (hsGal4; UAS-CBP-FLAD; + heat 
shocks) stained with the same antibody under the same conditions.  Note the dramatic 
reduction in staining intensity when the HAT-defective form of CBP is expressed. 
 53 
Figure	  3.9	  
	  
	  
	  
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
 54 
3.2.e:  Presenilin-Compromised Brains Also Exhibit Reductions in Global Acetylation. 
To investigate whether Psn affects the overall levels of acetylation of H4 in the adult 
brain (as expected if Psn affects CBP function), we compared the staining patterns of 
dissected brains in which CBP (Fig. 3.10A-C), Psn (Fig. 3.10D-F), and Notch (Fig. 
3.10G-I) had been silenced with RNAi.   For each gene, two control groups were 
analyzed [(hsGal4; UAS-RNAi; no heat shocks) (Fig. 3.10A, D, G)] and [(no Driver; 
UAS-RNAi; + heat shocks) (Fig. 3.10B, E, H)].  It is clear from the data presented that H4 
acetylation levels are drastically reduced in brains expressing UAS-CBPi (Fig. 3.10C), 
moderately reduced in brains expressing UAS-Psni (Fig. 3.10D), and unaffected in brains 
expressing UAS-Ni (Fig. 3.10I). 
These results demonstrate that CBP is needed for global acetylation in the adult brain, 
and they are consistent with our model that Psn controls the expression of CBP.  They 
also suggest, once again, that Notch has little or no effect on the function of CBP.  
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Figure 3.10:  Psn affects global acetylation levels in the adult brain. 
The above images are whole-mount adult fly brains stained for AC-H4-K8 to assay 
global acetylation levels.  (A,D,G) represent one control group (hsGal4; UAS-RNAi; no 
heat shocks),  (B,E,H) depict a second control group (no Gal4; UAS-RNAi; + heat 
shocks), and (C,F,I) represent the experimental group (hsGal4; UAS-RNAi; + heat 
shocks).  Note that when CBP is silenced there is a dramatic effect on global acetylation 
levels (compare C with the A and B controls); when Psn is silenced there is a significant 
but less dramatic effect (F); and when Notch is silenced (I) there is not noticeable effect.  
All brains were dissected, stained, and photographed using the same conditions and 
microscope settings. 
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3.2.f:  CBP-Compromised Flies Exhibit an Altered Geotactic Response. 
Having demonstrated that CBP is needed for global levels of acetylation in the adult 
brain, we next wanted to investigate what effect, if any, these reductions had on the 
biology of the fly.  In outward appearance, Drosophila compromised for CBP functions 
post development, appear normal.  Both males and females are fertile and their lifespan is 
not dramatically affected.  Thus in an effort to ascertain if they display any subtle 
behavioral phenotypes that might underlie neurological defects, we tested them for a 
normal geotactic response. 
Some of the earliest discoveries that revealed a genetic basis for complex behavior 
were made by analyzing geotaxis—the movement of an organism in response to gravity 
(Benzer 1967), (Erlenmeyer-Kimling & Hirsch 1961).  Drosophila exhibit strong 
negative geotaxis behavior because when placed in a tube, they prefer to climb toward 
the top.  In addition, mutant studies have identified several genes that are required for this 
complex behavior (Toma et al. 2002).  
Thus, to investigate whether CBP-compromised flies display an altered geotaxis, we 
built a countercurrent apparatus using specifications originally described by Benzer 
(1967).  This apparatus monitors progressive geotactic performance as described in the 
Materials and Methods chapter.  The number of heat shock treatments needed to 
effectively reduce CBP protein was determined by Western blot analysis shown in Figure 
3.12.  The following control groups exhibit normal CBP protein levels:  (hsGal4; UAS-
CBPi no heat shocks), and (no Gal4; UAS-CBPi with 7 heat shocks).  The first 
experimental group (hsGal4; UAS-CBPi with 5 heat shocks) shows no quantifiable 
reduction in CBP protein compared to the controls, whereas the experimental group 
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(hsGal4; UAS-CBPi with 7 heat shocks) exhibited a ~75% reduction in CBP protein.  
Based on these results we used 7 heat shock treatments to reduce CBP levels for the data 
presented in Figure 13 and 14.  Based on these western blot results CBP protein 
reduction, via RANi, is not progressive over the course of the heat shock regimen. The 
short time where CBP is reduced occurs around the 7th heat shock, which may only be a 
12-24 hour period.  Because of this short time, it is not expected that any observed 
behavioral phenotypes acquired through reduced CBP, are age-dependent, nor is 
neurodegeneration anticipated.  
The mean tube distribution for four different cohorts of flies —three controls (without 
driver, without responder, without heat shocks) and one experimental—are presented by 
a best-fit line in Figure 3.13.  Clearly most of the flies in the experimental group (hsGal4; 
UAS-CBPi; +heat shocks) were impaired in their ability to progress beyond the first tube.  
In addition, an ANOVA analysis of the data indicates that the performance of the 
experimental group is significantly impaired (F(3,53)=21.02; P<0.0001) compared to the 
performance of each control group (Fig. 14).  These results suggest that CBP is required 
in the adult animal for the maintenance of some normal behaviors, and the fact that CBP 
compromised flies display this behavior phenotype may be indicative of some time of 
neurological defect associated with its dysfunction. 
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Figure 3.11:  Assaying geotaxis using a countercurrent device. 
Pictured is the countercurrent device we built for assaying geotaxis behavior.  This 
apparatus was modeled directly from a similar design created by Seymor Benzer (1967).  
Each experiment starts as flies are placed in tube set 1 and given 3 sharp taps on a rubber 
mat to knock them to the bottom.  Flies are then given 10 seconds to climb into the upper 
tube, after which time it is moved over to the bottom of set 2.  They are again tapped to 
the bottom, allowed to climb for 10 seconds, and moved to the bottom of set 3.  The 
procedure continues until set 6 is reached.  At the end of the experiment, the percentage 
of the fly cohort in each tube is calculated.  The experiment is calibrated in such a way 
that most of the wildtype flies (exhibiting normal negative geotaxis) accumulate in tube 
number six. 
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Figure 3.12:  Western analysis determines the number of heat shocks required to 
effectively reduce CBP through RNA interference. 
     The following western blot reveals that 7 heat shocks were needed to reduce CBP 
protein levels effectively.  For the heat shock regimen see the Material and Methods 
chapter.  The first two lanes and the last lane are control lanes (hsGal4; UAS-CBPi no 
hs), (no Gal4; UAS-CBPi [7] hs), and (hs-CBP [2] hs).  The second and third lanes are 
experimental (hsGal4; UAS-CBPi [5] hs) and (hsGal4; UAS-CBPi [7] hs).  Alpha tubulin 
was used as a loading control.	  	  The	  histogram	  shows	  a	  ~70%	  reduction	  in	  CBP	  protein	  
levels	  compared	  to	  the	  non-­‐heat	  shock	  control	  group	  in	  the	  first	  lane.	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Figure 3.13:  Flies compromised for CBP exhibit poor geotaxis. 
The following graph represents the mean distribution of flies within each tube after 5 
successive trials.  Tube distribution for each group is presented by a best-fit line, which is 
based on a linear regression.  The slope of the experimental group (hs-Gal4; UAS-CBPi) 
indicates that the majority of these cohorts remained in the first sets of tubes, whereas the 
control group accumulated in the last sets of tubes.  
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Figure 3.14:  Geotaxis performance scores. 
  Mean performance scores for each group are shown (see Material and Methods 
chapter for a description).  This graph represents the mean score for each group with a 
significant difference between the experimental group (hsGal4; UAS-CBPi; +heat 
shocks) and all three control groups (F(3,53)=11.8; P<0.0001).  There were no significant 
differences between genders or control groups.  A (+) indicates a heat shock treatment 
and (-) indicate no heat shock.   
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3.3:  Discussion. 
Based on the data presented in this report, we have provided clear evidence to support 
the conclusion that CBP is required to maintain global levels of Histone H4 acetylation in 
the adult Drosophila CNS.  We base our conclusions on the powerful combination of 
using both loss-of-function (expression of RNAi against CBP) and dominant-negative 
(expression of CBP-FLAD) genetic reagents (Fig. 3.6; Fig. 3.9).  We also show that when 
CBP expression is uncoupled from development and conditionally silenced only in 
adults, we detect subtle changes in the behavior of the fly than can be easily quantified in 
a geotaxis assay (Fig. 3.14).  Because CBP is a multifunctional protein that co-activates 
so many genes and because CBP deficiencies have drastic developmental effects, our 
results are surprising in the sense that the phenotype described in these adult flies is not 
more severe.  There are at least two possible explanations for this observation.   
The first concerns the limitations of the inducible RNAi strategy, and the fact that 
after multiple rounds of heat shocks CBP is not completely silenced (Fig. 3.12).  Thus, 
the remaining low levels of CBP may supply enough vital functions for the fly.   The 
second possibility speaks to the function of CBP in acetylating histones, and the fact that 
we monitored the K8 residue on Histone 4.  In this model, the adult nervous system is 
supplied with wildtype levels of CBP during development, but as levels drop during our 
experimental manipulations of aging adults, histone modifications required for more open 
chromatin configurations are slowly being eroded.  Thus, subtle nervous system activities 
that control behavioral functions, such as negative geotaxis, would likely be affected first, 
followed by more vital functions.  Based on our observations with Notch loss-of-function 
manipulations in adults (Presente et al. 2004), we favor the later explanation, and we are 
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currently testing this model further by examining more complex behaviors such as 
learning and memory under conditions in which Psn and CBP are compromised in aging 
animals.  Finally if this model is correct, understanding the role of CBP (and molecules 
that affect its activity such as Psn) in an aging nervous system, might have important 
implications for the study of human neurodegenerative diseases.  For example, subtle 
genetic mutations in CBP may be amplified if a person has a specific environmental 
exposure to an agent that modifies chromatin structure.  
A second significant conclusion from this report is that we clearly established 
relationship between Psn and CBP protein accumulation and function in the fly.  We 
show that when Psn is silenced with RNAi, we see dramatically reduced levels of CBP 
Protein (Fig. 3.6) and similar effects on global aceylation levels of K8 on Histone 4 (Fig. 
3.9).  In addition, our results are interesting because reports examining the link between 
Psn and CBP in mice are contradictory.  One group reported that the Psn-processed N-
cadherin ICD targets CBP for degradation, and that PS1 FAD-linked mutant mouse 
embryonic fibroblasts showed increased levels of CBP protein (Marambaud et al. 2003).  
However, another reported that conditional knockdowns of both Psn homologues 
(PS1/PS2) showed a reduction in CBP protein and mRNA levels in the mouse 
hippocampus (Saura et al. 2004).  Perhaps the fly system can be used in combination with 
the mouse system to clear up the discrepancy and/or speak to the divergent pathways that 
can explain these results in vertebrates.  In either case the relationship between Psn 
activity and CBP expression is probably not direct given our understanding of Psn as a 
transmembrane protein that processes type I receptors.   
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We and others have clearly demonstrated the when Notch is compromised in the 
nervous system of adult animals (flies or mice) LTM is specifically impaired (Presente et 
al. 2004), (Ge et al. 2004), and (Costa et al. 2003).  Thus, we began this analysis with the 
expectation that Notch, Psn, and CBP would be linked in a common pathway in which a 
Psn-processed form of Notch would co-activate target genes that regulated global 
acetylation levels.  The model was attractive because it had the potential to connect a 
molecular “memory” of histone acetylation and placement with an organic explanation of 
how an organism’s long-term memory is either established or maintained.  We were 
encouraged to pursue this model when we were able to identify four putative Su(H) 
binding sites within 2.1 kB of the start of transcription of CBP (Fig. 3.3), but we were 
unable to show that compromising Notch had any effect on CBP RNA levels, CBP 
protein levels, or K8 Histone 4 acetylation (Fig. 3.4, Fig. 3.10I).  Also, mouse brains 
compromised for Psn show reduced CREB activity, where early hypotheses suggested 
that Psn influences CRE-regulated genes through Notch signaling-induced CBP 
coactivation (Saura et al. 2004).  However, a recent report shows that Notch signaling 
does not directly affect CREB activity (Watanabe et al. 2009).  Nevertheless it still 
remains a formal possibility that in key neurons of the fly brain that control LTM, a large 
reduction in Notch could have a subtle reduction in CBP, and that this subtle reduction is 
responsible for the LTM phenotype that is observed. 
We are still unsure how Psn and CBP are connected at the molecular level.  One 
possibility is that Psn processing of another Type I receptor leads to a transcriptional 
control of CBP.  We attempted to address this possibility by collecting and testing several 
Type I receptor lines from the Vienna Drosophila RNAi Center in which an inverted 
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repeat of sequence unique for each of 17 Type I receptors was cloned under UAS control.  
Unfortunately we were unable to detect any effects on CBP mRNA levels as judged by 
qRT-PCR (table 2).   A second possibility is that the activity of some of the protein 
targets that interact non-catalytically with Psn may become altered when Psn is reduced, 
and their dysfunction might affect CBP expression or stability.  However, a third 
possibility exists that Psn regulates CBP through a mechanism that is currently unknown.   
Regardless of mechanism, our data clearly link Psn and CBP in a pathway that is 
required for normal acetylation levels and for normal behavioral activities.   In the 
vertebrate literature, Psn is linked to AD, and CBP is associated with specific mental 
disorders including Rubenstein-Taybi and Huntington’s disease.  
Although there has been an extensive investigation into the role of Aβ42 in AD, there 
remain many unanswered questions.  The biggest hurdle associated with the “Amyloid 
hypothesis” is that Aβ plaques have never been correlated directly to the 
neurodegeneration associated with AD.  These gaps in Aβ research have given rise to 
alternative hypotheses, the most notable being the “Presenilin hypothesis” (reviewed by 
(Shen & Kelleher 2007)).  This model suggests that the mutated forms of Psn associated 
with AD not only miscleave APP, but also miscleave other substrates that result in a loss 
of signal.  Such signal disruptions have been reported with Ncadherin, Notch, and 
NMDAR activity, where any one of these (or their combinations) could reduce 
downstream target expression manifesting the symptoms of AD (Marambaud et al. 2003), 
(Schroeter et al. 2003), (Moehlmann et al. 2002), and (Saura et al. 2004).  Therefore, it is 
possible that Aβ plaque formation is more of a terminal phenotype with regards to the 
age of the disease, and that the onset of pathology occurs much earlier through subtle 
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losses in these signaling pathways.  One such model for this is presented in this report 
where reduced Psn leads to CBP reduction and dysfunction resulting in decreased global 
histone acetylation. 
The rapidly increasing list of Psn substrates and associating proteins not only suggests 
a broader role for Psn, but also reveals new therapeutic targets in AD research.  The use 
of HDAC inhibitors may prove to be useful as a treatment designed to arrest the 
neurodegeneration associated with AD, but the cause for these certain forms of AD may 
reside in the increasingly complex networks integrated through Psn, and therefore more 
research is needed to elucidate their functions.  
3.5:  Supplemental data not submitted for publication. 
Presenilin (Psn) is the catalytic subunit of the γ-secretase complex located in the 
plasma transmembrane. Recent focus has been directed towards this protein because 
certain mutated forms have been implicated in the inherited form of Alzheimer’s disease 
(AD). Psn processes about 30 known substrates, usually type I transmembrane receptor, 
where the freed intracellular domain (ICD) translocates to the nucleus to affect gene 
transcription. There have been several reports revealing that these mutated forms of Psn 
result with incorrect substrate processing that could disrupt receptor signaling or produce 
harmful byproducts. The most notorious example is the Aβ fragment, which is released 
through improper processing of Amyloid Precursor Protein (APP).  These fragments 
aggregate and forms plaques on AD-afflicted brains. In an attempt to uncover possible 
downstream genes that may be affected by this disruption in receptor signaling we found 
that the level of a multifunctional protein called CREB Binding Protein (CBP) is severely 
reduced in a Psn-silenced background. This is interesting because certain mammalian 
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systems with reduced CBP show cognitive problems including mental retardation in 
humans. Therefore, it is possible that a reduction in CBP could be a contributing factor in 
AD. It is probable that Psn does not directly influence CBP levels, but through an 
intermediate signaling molecule, most likely one of its processed substrates.  Identifying 
this intermediate molecule is important because it could ultimately be a therapeutic target 
in AD treatment. To that purpose, we have performed an RNAi-based screen designed to 
reveal a pool of possible intermediate signaling molecules that may ultimately influence 
CBP levels.    
This screen consists of 18 RNAi lines that target the transcripts of Psn substrates and 
3 additional lines that target the Psn non-catalytic associating protein transcripts.  The 
goal of the screen was to reveal the possible intermediate signaling molecule(s) that may 
be in the same pathway as Psn and CBP.  Each RNAi line was crossed to a wing, eye, and 
thorax Gal4 driver (c96-Gal4, GMR-Gal4, pnr-Gal4), which are the same used in an 
earlier screen (see chapter 3).  The progeny from this cross were then scored on the 
severity of the RNAi-induced phenotype (Table 1).  qRT-PCR analysis was used to 
monitor the transcription of CBP mRNA relative to a control for four of these RNAi lines 
(Table 2).  
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Table S.1 
	  
	  
Presenilin Substrates c96-Gal4 
GMR-
Gal4 pnr-Gal4 
Mammalian Name Drosophila Name       
ApoE R2 LpR1 0 0 0 
DCC Sidekick 0 0 0 
DCC Frazzled 0 0 0 
Ephrin D-Ephrin 0 0 0 
Typosinase Black Cells 0 0 0 
  Dachsous 0 0 1 
App App1 0 0 1 
Nectin 1a Kirre 0 0 2 
LRP Arrow 0 1 2 
γ-Protocadherin Cad99C 0 1 1 
CSF1 PvR 0 1 3 
CD44   0 2 2 
N-cadherin Cadherin N 0 2 3 
Jagged Serrate 2 1 0 
Delta Delta 0 Lethal 3 
GHR Sallimus 4 2 2 
E-cadherin Shotgun 2 4 4.5 
P75 Srp54 3 0 4 
Presenilin Associating Proteins c96-Gal4 
GMR-
Gal4 pnr-Gal4 
Mammalian Name Drosophila Name       
Gsk3B Shaggy 0 2 4.5 
NMDA-R NMDA-R 0 2 2 
B-catenin Armadillo 4 3 2.5 
	  
	  
*The numerical scores used in this table are subjective and describe 
phenotypic severity where the least severe is 0 and the most severe is 5.  
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Figure S.1: Phenotypic Examples Derived from the RNAi Screen 
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Table	  S.2	  	  qRT-­PCR	  Results	  
	  
Wildtype 1.0    
hs-gal4/+ 2.1 
UAS-Ni/hs-gal4 1.0 
hs-N 1.9 
hs-Gal4/UAS-Ncadi 1.7 
hs-Gal4/UAS-Ecadi 1.7 
hs-Gal4/UAS-Armi 0.5 
hs-Gal4/UAS-Arm+ 2.2 
hs-Gal4/UAS-NMDARi 1.7 
UAS-Psn-8309/hs-gal4 23.8 
hs-CBP 69.3 
*The above table represents qRT-PCR results representing the 
relative quantity of CBP mRNA transcribed by each genotype.  
The number corresponding to each genotype was normalized to 
wildtype CBP transcription.  
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Figure S.2:  Phenotypic Screen for the most effective RNAi lines. 
The following images are the results of a screen used to determine the most effective 
RNAi line based on the severity of three developmental phenotypes in the eye, thorax, 
and wing.  The same Gal4 drivers were used as in Supplemental Data A.  Transgenic 
RNAi lines that target specific genes usually vary in their effectiveness at silencing its 
targeted gene.  This is usually due to where the transgenic element inserts into the 
genome i.e., high expressing regions vs. low expressing regions, and the mRNA sequence 
targeted by the RNAi molecule.  Therefore it is common to analyze multiple lines using a 
screen similar to this one, where not only can an observable phenotype be easily detected, 
but also variances in that phenotype can be used to gauge each line within its respective 
group.   
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CHAPTER 4 
NOTCH DYSFUNCTION RESULTS IN REDUCED NEURITE OUTGROWTH IN 
CULTURED PRIMARY NEURONS 
The following chapter is part of a manuscript being prepared for publication. 
My contribution to this work is as follows:  I made all the genetic crosses, cultured the 
primary neurons, measured the neurites, and performed all of the statistical analyses.  Our 
collaborators Linda Restifo and Robert Kraft provided us with the use of reagents and the 
equipment used to grow the neurons. 
4.1:  Introduction. 
     Subtle perturbations in the complex network of neurons and their ultrastructure are 
oftentimes difficult to detect (Kraft et al. 2006).  This is especially true at the level of the 
synapse, where function relies in part on morphological design (Rohrbough et al. 2003).  
The plasticity at the synapse does not remain static, and external cues can direct the 
dynamic changes necessary for learning, memory, and the maintenance of a properly 
functioning nervous system (Dubnau et al. 2003).  These networks rely on several 
intricate signaling pathways where their loss of signal through gene mutation or 
dysfunction is seemingly more difficult to identify because they regularly do not leave a 
footprint as do the majority of gain of function mutations, which may appear obvious, i.e. 
Aβ plaques on Alzheimer diseased brains (Kraft et al. 2006)(Shen & Kelleher 2007).  
Therefore it is sometimes necessary to induce specific gene dysfunction in vitro, thereby 
isolating these neurons from their normal highly supportive social environment, in an 
attempt to tease out these subtle phenotypes that would normally go unnoticed. 
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     Our lab has previously shown that when Notch is conditionally silenced in adult 
Drosophila they display long-term memory impairments (Presente et al. 2004).  
However, we observed no discernable physiological phenotype when we analyzed these 
Notch-deficient flies for brain morphology and bouton number of innervated larval body 
wall muscles.  Therefore we required a more powerful assay in order to test the model 
whereby the Notch-induced behavioral impairments can be connected to a gross 
physiological phenotype. 
     The technique of culturing primary neurons has proven highly effective at identifying 
previously unseen phenotypes for several different model systems, which have provided 
for new insights into possible mechanisms for neurological disease pathologies (Kraft et 
al. 1998)(Romijn et al. 1981).   
      To that end we have analyzed primary cultured neurons that are silenced for Notch in 
specific lobes of an established larval central nervous system.  These neurons do exhibit 
severely reduced neurite outgrowth and showed significant differences compared to the 
control, when examined for four specific parameters using the semi-automated statistical 
software called Neuronmetrics (Narro et al. 2007). 
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4.2:  Results. 
     In an attempt to link LTM impairments derived from conditionally Notch-silenced 
Drosophila to an observable structural phenotype in the central nervous system, we 
employed the well-established technique for culturing the primary neurons of wandering 
third instar larvae.  This is a method for revealing phenotypes that normally are concealed 
by the complexities of an intricate nervous system (Kraft et al. 2006).  
     The larval CNS is removed through dissection and the cells are dissociated and 
cultured in media for three days.  The transgenic neurons are identified through Gal4-
directed GFP expression in a field of non-GFP-expressing neurons (Fig. 4.1 B).  Roughly 
60 images of each group are taken and analyzed by Neuronmetrics software for four 
categories (Fig. 4.1 A). 
     Our goal was to determine if induced Notch dysfunction would result in quantifiable 
neurite differences among control (247-Gal4; UAS-GFP) and experimental (247-GFP; 
UAS-Ni; UAS-GFP) groups.  As presented in figure 4.2 the example of a Notch-reduced 
neuron (bottom image) shows an obvious reduction in all for analyzed categories 
including:  number of primary neurons, branchiness, neurite length, and total area 
covered, when compared to the extensive arborization of the control neuron (top image).   
     The images for each group were quantified by Neuronmetrics (Fig. 4.3).   Three of the 
four categories exhibited highly significant differences (p<0.0001).  The category for the 
number of primary extensions was slightly less significant (p<0.024) based on a Mann-
Whitney rank sum test.  Therefore based on these results, Notch is required for proper 
neurite regrowth, which may result in subtler phenotypes at the synapse. 
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Figure 4.1:  Example of Neuron Analysis Using Neuronmetrics™ . 
     Neuronmetrics™ is a semi-automated computer program that is used to measure 
neurites (Fig. A) in the following categories: 1) number of primary processes (neurites 
that directly extend from the cell body), 2) branchiness, 3) total neurite length, and 4) 
territory occupied by the neuron (area calculated by surrounding the neuron with a best-
fit polygon).   
     Figure B is the mushroom body from a third instar larvae (247-gal4; UAS-GFP), 
identified with green fluorescent protein (GFP).    
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Figure 4.1 
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Figure 4.2:  Notch-Reduced Neurons Exhibit Reduced Neurite Outgrowth. 
     Figures A and B are example images of neurons from the control group 247-gal4; 
UAS-GFP and the Notch-reduced group 247-gal4; UAS-Ni;UAS-GFP respectively.  
Notice the size and complex arborization in the control group (A) compared to the 
“stunted” linear arrangement in the Notch-reduced group (B). 
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Figure 4.2 
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Figure 4.3:  Statistical Analysis Quantifies Notch-Reduced Phenotype. 
     A Mann-Whitney rank sum test was used to determine any statistical differences, 
where the range of the box is from the 25th percentile to the 75th percentile, the arrowhead 
indicates the median, and the bars indicate the 10th and 90th percentile.  Sixty neurons 
were measured in each group and identified in culture as mushroom body neurons by 
GFP expression.  A gray box represents data for W1118; 247-gal4; UAS-GFP neurons, and 
247-gal4; UAS-Ni;UAS-GFP neuron data are represented by the red box.   
     The number of primary processes is significantly reduced in the Ni group (p=0.0024).   
More compelling significant differences, between Ni and the control, were seen in the 
remaining three measurements including, branchiness, total neurite length, and territory 
occupied by neuron, where the p-value for these groups was P<0.0001. 
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Figure 4.3 
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4.3:  Discussion. 
     Notch is very well characterized for its role in binary cell fate decisions during 
nervous system development.  Although Notch is highly expressed during this 
developmental period, observations in Drosophila, mouse, and human systems show that 
these levels drop considerably in postmitotic adults where Notch is expressed at low 
levels (Presente et al. 2002).  Because Notch is present in adults and the apparent LTM 
impairments associated with Notch dysfunction suggest a role for Notch beyond 
development.  
     Interestingly, there are reports that show transfection of Notch 1 in mouse 
hippocampal primary neurons results in reduced neurite outgrowth, which suggests an 
inhibitory role for Notch in neurites (Berezovska, P. McLean et al. 1999a)(Berezovska, 
Frosch et al. 1999b).  These results are strikingly similar to ours when we silence Notch 
in larval primary MB neurons.  There are several possibilities for these contradictory 
results.  The first could simply be subtle differences between these model organisms.  
The second however, could be that the mouse primary neurons used were embryonic.  
Although these neurons are post mitotic, the organism is still in the womb and at the very 
early stages of development, whereas the larval MB neurons used in this report derived 
from a fully intact CNS, and furthermore, larvae directly interact with their environment 
and are maternally independent.  Although these larvae will eventually undergo 
metamorphosis, the MB lobes that house these neurons either remain consistent through 
metamorphosis, or are remodeled for higher order structures.  Finally, a third possibility 
is that Notch within specific contexts, may have varying functions that could provide for 
these conflicting results.  
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     Several reports have shown that memory is impaired in the absence of Notch (Presente 
et al. 2004)(Costa et al. 2003)(Ge et al. 2004).   One report however, tested the cognitive 
effects of overexpression of Notch adult Drosophila and found that LTM was enhanced 
(Ge et al. 2004).  This is consistent with our results which suggest that the requirement 
for Notch in the post-mitotic CNS is not inhibitory, but necessary for maintaining a 
properly functioning nervous system.  
     Notch loss of signal has implications in disease (see Introduction chapter).  Losses in 
Notch signaling have been reported in those afflicted with the famlial form of 
Alzheimer’s disease (Selkoe 2001).  The majority of these cases are thought to be caused 
by mutations in the Presenilin gene (Psn).  Psn is intramembraneous and thought to 
process Notch in a manner that frees its signaling domain.  It is possible that these 
mutated forms of Psn are not processing Notch efficiently resulting in both loss of signal 
and target gene expression.  Based on our data and others, this could lead to memory 
impairment, neuronal dysfunction, and even neurodegeneration, which are commonly 
observed in AD patients.  Therefore if reductions in Notch contribute to AD 
manifestation, perhaps this could lead to new therapeutic targets designed to arrest AD 
pathology.  
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CHAPTER 5 
CONCLUDING REMARKS 
This study demonstrates that CBP is a downstream target of Psn in the adult 
Drosophila CNS.  The cell and molecular data presented here clearly show that 
diminished CBP levels and function occur in the absence of Psn.  These results should 
help clarify the controversial reports that discuss the interactions of these two proteins.  
Additionally, these are the first data that suggest Notch does not regulate CBP expression 
even though the mouse and Drosophia CBP enhancer contain putative Su(H)/CBF1/RBP-
Jκ binding sequences.   
Although these data suggest that Notch does not influence CBP expression, the 
methods that we used to identify this putative association were more of a global 
approach, i.e., Western blot using whole fly heads, or CBP antibody staining in the entire 
CNS.  It is possible that Notch does affect CBP expression in a subset of neurons that 
would go undetected using our techniques.  The mechanism for which Notch is required 
in memory is still not known, therefore further analysis may be required in, perhaps, 
more specific nervous system tissue to completely rule out an association between Notch 
and CBP expression.   
The memory and neurite phenotypes derived from Notch dysfunction are comparable 
to the cognitive and neurodegenerative conditions associated with AD, which suggests 
that Notch dysfunction could possibly contribute to the pathology of this disease.  
Although Notch signaling does not fit into our Psn/CBP model, the possibility that it 
could be a causative agent in AD manifestation, via an alternative or redundant pathway, 
should not be overlooked. 
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The association between Psn and CBP is probably not direct, but through an 
intermediate signaling molecule most likely mediated through Psn processing.  The 
identification of this intermediate is important because it could be an effective therapeutic 
target.  Its detection however, may prove difficult based on the rapidly accumulating 
number of Psn substrates and associating proteins.  The RNAi screen presented in the 
supplemental data in chapter 3 focused on 17 Psn substrates and 3 association proteins.  
Although a few of these RNAi lines produced phenotypes consistent with those observed 
in Psn and CBP-silenced developmental tissues, qRT-PCR data demonstrated that when 
these genes are silenced, CBP transcription is relatively unaffected.  This suggests a few 
things; the first is that we could simply have not used the correct RNAi line yet, but could 
with further investigation; alternatively, the substrate may not have been discovered yet; 
and finally the link between Psn and CBP may be a network of several of these signaling 
molecules.  Therefore, it could take a while before the components in this pathway are 
identified. 
We have shown that a complex behavior (geotaxis) is impaired when CBP is 
conditionally reduced in adult flies.  Other studies using the mouse system have shown 
that induced CBP dysfunction in mice resulted in not only LTM, but also a STM memory 
impairment (Lonze & Ginty 2002)(personal communication with Jie Shen).  It would be 
interesting to see if Drosophila also exhibit both a short and long-term memory 
phenotype.  The effects of conditionally-silenced Psn in adult Drosophila should also be 
analyzed for both of these phases of memory.  If flies dysfunctional for Psn exhibit 
memory impairments, an attempt to rescue this phenotype should be made by ectopically 
expressing CBP.  
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Finally, we have shown that both Psn and CBP-silenced flies have global reductions 
in histone acetylation.  This type of chromatin remodeling is normally associated with 
gene activation.  Reductions in acetylation could result in the silencing of genes required 
for maintaining a properly functioning nervous system.  This could be mechanism for 
memory impairments associated with the knockdown of these genes in mice and a 
possible contributing factor to FAD that directly results from mutant forms of Psn.  If a 
link between AD and histone acetylation can be demonstrated, the use of HDAC 
inhibitors may prove useful in ameliorating the effects of this disease. 
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